Cerus Endovascular announced today that it received FDA investigational device exemption for a trial for its Contour Neurovascular System.
Fremont, Calif.-based Cerus’ Contour Neurovascular System is designed to treat intracranial aneurysms. It is made of fine mesh braid to target the neck of the aneurysm away from the vulnerable dome.